Related references
Note: Only part of the references are listed.Characterization of the Epitope Region of F1-2 and F1-5, Two Monoclonal Antibodies to Botulinum Neurotoxin Type A
Miles C. Scotcher et al.
HYBRIDOMA (2009)
Antibody Protection against Botulinum Neurotoxin Intoxication in Mice
Luisa W. Cheng et al.
INFECTION AND IMMUNITY (2009)
Neutralizing Antibodies of Botulinum Neurotoxin Serotype A Screened from a Fully Synthetic Human Antibody Phage Display Library
Rui Yu et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Development and partial characterization of high-affinity monoclonal antibodies for botulinum toxin type A and their use in analysis of milk by sandwich ELISA
Larry H. Stanker et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
High-throughput homogeneous immunoassay readily identifies monoclonal antibody to serovariant clostridial neurotoxins
Cindi R. Corbett et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route
Easwaran Ravichandran et al.
INFECTION AND IMMUNITY (2007)
Creation and development of the public service orphan drug human botulism immune globulin
Stephen S. Arnon
PEDIATRICS (2007)
Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A
Behzod Z. Dolimbek et al.
MOLECULAR IMMUNOLOGY (2007)
Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display
R. Levy et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Identification of the protein receptor binding site of botulinum neurotoxins B and G oroves the double-receptor concept
Andreas Rummel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin
Consuelo Garcia-Rodriguez et al.
NATURE BIOTECHNOLOGY (2007)
Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity
Rongsheng Jin et al.
NATURE (2006)
Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen
Michael J. Gubbins et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey
James Boles et al.
TOXICON (2006)
SV2 is the protein receptor for botulinum neurotoxin A
M Dong et al.
SCIENCE (2006)
Laboratory diagnostics of botulism
M Lindström et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Human botulism immune globulin for the treatment of infant botulism
SS Arnon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region
R Mabry et al.
INFECTION AND IMMUNITY (2005)
Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E
MR Baldwin et al.
INFECTION AND IMMUNITY (2005)
Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale
JD Berry
VETERINARY JOURNAL (2005)
Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralizaiion
TJ Smith et al.
INFECTION AND IMMUNITY (2005)
The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction
A Rummel et al.
MOLECULAR MICROBIOLOGY (2004)
Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus
JD Berry et al.
JOURNAL OF VIROLOGICAL METHODS (2004)
Mapping of the antibody-binding regions on the H-N-domain (residues 449-859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A
MZ Atassi et al.
PROTEIN JOURNAL (2004)
A case of type F botulism in southern California
WH Richardson et al.
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY (2004)
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody
A Nowakowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A
HC Wu et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Botulinum toxin as a biological weapon - Medical and public health management
SS Arnon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A
DD Pless et al.
INFECTION AND IMMUNITY (2001)
Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B
S Swaminathan et al.
NATURE STRUCTURAL BIOLOGY (2000)